T-lymphocyte differentiation and proliferation in the absence of the cytoplasmic tail of the common cytokine receptor γ(c) chain in a severe combined immune deficiency X1 patient

Blood

Volumn 88, Issue 5, 1996, Pages 1708-1717

  Morelon, Emmanuel ^b   Dautry Varsat, Alice ^b   Le Deist, Françoise ^b   Hacein Bay, Salima ^b   Fischer, Alain ^b   De Saint Basile, Geneviève ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE RECEPTOR; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 7; INTERLEUKIN 9; MITOGENIC AGENT;

ARTICLE; BONE MARROW TRANSPLANTATION; CASE REPORT; CHIMERA; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; E ROSETTE; ENDOCYTOSIS; FAILURE TO THRIVE; HUMAN; HUMAN CELL; INFANT; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RECEPTOR DOWN REGULATION; T LYMPHOCYTE SUBPOPULATION;

EID: 0029794558     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.5.1708.1708     Document Type: Article

References (68)

1. Report of a WHO Scientific: Primary immunodeficiency diseases, in Rosen FS, Seligmann M (eds): Immunodeficiencies. Philadelphia, PA, Harwood Academic Publishers, CHUR, 1993, p I
2. Stephan J, Vlekova V, Le Deist F, Blanche S, Donadieu J, De Saint Basile G, Durandy A, Griscelli C, Fischer A: Severe combined immunodeficiency: A retrospective single-center study of clinical presentation and outcome in 117 cases. J Pediatr 123:5047, 1993
3. Puck JM, Nussbaum RL, Conley ME: Carrier detection in X-linked severe combined immunodeficiency based on patterns of X chromosome inactivation. J Clin Invest 79:1395, 1987
4. Wengler GS, Allen RC, Parolini O, Smith H, Conley ME: Nonrandom X chromosome inactivation in natural killer cells from obligate carriers on X-linked severe combined immunodeficiency. J Immunol 150:700, 1993
5. Noguchi M, Yi H, Rosenblatt HM, Filipovich AH, Adelstein S, Modi WS, McBride OW, Leonard WJ: Interleukin-2 receptor γ chain mutation results in X-linked severe combined immunodeficiency in humans. Cell 73:147, 1993
6. Minami Y, Kono T, Miyazaki T, Taniguchi T: The IL2 receptor complex: Its structure, function, and target genes. Annu Rev Immunol 11:245, 1993
7. Kondo M, Takeshita T, Ishii N, Nakamura M, Watanabe S, Arai K-I, Sugamura K: Sharing of the interleukin 2 (IL2) receptor γ chain between receptors for IL2 and IL4. Science 262:1874, 1993
8. Kondo M, Takeshita T, Higuchi M, Nakamura M, Sudo T, Nishikawa S-I, Sugamura K: Functional participation of the IL2 receptor γ chain in IL7 receptor complexes. Science 263:1453, 1994
9. Russell SM, Keegan AD, Harada N, Nakamura Y, Noguchi M, Leland P, Friedmann MC, Miyajima A, Puri RK, Paul WE, Leonard WJ: Interleukin-2 receptor γ chain: A functional component of the interleukin 4 receptor. Science 262:1880, 1993
10. Giri JG, Ahdieh M, Eisenman J, Shanebeck K, Grabstein K, Kumaki S, Namen A, Park LS, Cosman D, Anderson D: Utilization of the β and γ chains of the IL2 receptor by the novel cytokine IL15. EMBO J 13:2822, 1994
11. c chains with Jak1 and Jak3: Implications for XSCID and XCID. Science 266:1042, 1994
12. Nakamura Y, Russell SM, Mess SA, Friedmann M, Erdos M, Francois C, Jacques Y, Adelstein S, Leonard WJ: Heterodimerization of the IL2 receptor β and γ chain cytoplasmic domains is required for signaling. Nature 369:330, 1994
13. Miyazaki T, Kawahara A, Fujii H, Nakagawa Y, Minami Y, Liu Z-J, Oishi I, Silvennoinen O, Witthuhn BA, Ihle JN, Taniguchi T: Functional activation of Jak1 and Jak3 by selective association with IL2 receptor subunits. Science 266:1045, 1994
14. Duprez V, Dautry-Varsat A: Receptor mediated endocytosis of interleukin 2 in a human tumor T cell line: Degradation of interleukin 2 and evidence for the absence of recycling of interleukin 2 receptors. J Biol Chem 261:15450, 1986
15. Duprez V, Ferrer M, Dautry-Varsat A: High-affinity interleukin 2 receptor α and β chains are internalized and remain associated inside the cells after interleukin 2 endocytosis. J Biol Chem 267:18639, 1992
16. Ferrer M, Hémar A, Duprez V, Hellio R, Dautry-Varsat A: Both the α and β chains of high-affinity interleukin 2 receptors are located in intracellular vesicles when their ligand is endocytosed. Eur J Cell Biol 60:276, 1993
17. Hémar A, Subtil A, Lieb M, Morelon E, Hellio R, Dautry-Varsat A: Endocytosis of interleukin 2 receptors in human T lymphocytes: Distinct intracellular localization and fate of the receptor α, β and γ chains. J Cell Biol 129:55, 1995
18. Hémar A, Lieb M, Subtil A, DiSanto JP, Dautry-Varsat A: Endocytosis of the β chain of interleukin 2 receptor requires neither interleukin 2 nor the γ chain. Eur J Immunol 24:1951, 1994
19. DiSanto JP, Dautry-Varsat A, Certain S, Fischer A, de Saint Basile G: IL-2Rγ chain mutations in SCIDX1 result in the loss of high-affinity IL-2 receptor binding. Eur J Immunol 24:475, 1994
20. DiSanto JP, Rieux-Laucat F, Dautry-Varsat A, Fischer A, de Saint Basile G: Defective human interleukin 2 receptor γ chain in an atypical X chromosome-linked severe combined immunodeficiency with peripheral T cells. Proc Natl Acad Sci USA 91:9466, 1994
21. Noguchi M, Adelstein S, Cao X, Leonard WJ: Characterization of the human interleukin 2 receptor γ chain gene. J Biol Chem 268:13601, 1993
22. Allen RC, Belmont JW: Trinucleotide repeat polymorphism at DXS101. Hum Mol Genet 2:1508, 1993
23. Landman-Parker J, Le Deist F, Blaise A, Brison O, Fischer A: Partial engraftment of donor bone marrow cells associated with long-term remission of haemophagocytic lymphohistiocytosis. Br J Haematol 85:37, 1993
24. Duprez V, Cornet V, Dautry-Varsat A: Down regulation of high affinity interleukin 2 receptors in a human tumor T cell line: IL2 increases the rate of surface receptor decay. J Biol Chem 263:12860, 1988
25. Duprez V, Lenoir G, Dautry-Varsat A: Autocrine growth stimulation of a T-cell lymphoma line by IL2. Proc Natl Acad Sci USA 82:6932, 1985
26. Teshigawara K, Wang H, Kato K, Smith KA: Interleukin 2 high-affinity receptors expression requires two distinct binding proteins. J Exp Med 165:223, 1987
27. Voss SD, Leary TP, Sondel PM, Robb RJ: Identification of a direct interaction between interleukin 2 and the p64 interleukin 2 receptor γ chain. Proc Natl Acad Sci USA 90:2428, 1993
28. Ishii N, Takeshita T, Kimura Y, Tada K, Kondo M, Nakamura M, Sugamura K: Expression of the interleukin 2 receptor γ chain on various populations in human peripheral blood. Int Immunol 6:1273, 1994
29. Hémar A, Dautry-Varsat A: Cyclosporin A inhibits the interleukin 2 receptor α chain gene transcription but not its cell surface expression: The α chain stability can explain this discrepancy. Eur J Immunol 20:2629, 1990
30. Robb RJ, Munck A, Smith KA: T cell growth factor receptors: Quantification, specificity, and biological relevance. J Exp Med 154:1455, 1981
31. Macchi P, Villa A, Giliani S, Sacco MG, Frattini A, Porta F, Ugazio AG, Johnston JA, Candotti F, O'Shea JJ, Vezzoni P, Notarangelo LD: Mutations of Jak 3 gene in patients with autosomal severe combined immune deficiency (SCID). Nature 377:65, 1995
32. Russell SM, Tayebi N, Nakajima H, Riedy MC, Roberts JL, Aman MJ, al e: Mutation of Jak3 in a patient with SCID: Essential role of jak3 in lymphoid development. Science 270:797, 1995
33. Asao A, Takeshita T, Ishii N, Kumaki S, Nakamura M, Sugamura K: Reconstitution of functional interleukin 2 receptor complexes on fibroblastoid cells: Involvement of the cytoplasmic domain of the γ chain in two distinct signaling pathways. Proc Natl Acad Sci USA 90:4127, 1993
34. Trowbridge IS, Hopkins CR: Signal-dependent membrane protein trafficking in the endocytic pathway. Annu Rev Cell Biol 9:129, 1993
35. Glenney JR, Jr, Chen WS, Lazar CS, Walton GM, Zokas LM, Rosenfeld MG, Gill GN: Ligand-induced endocytosis of the EGF receptor is blocked by mutational inactivation and by microinjection of anti-phosphotyrosine antibodies. Cell 52:675, 1988
36. Wiley HS, Herbst JJ, Walsh BJ, Lauffenburger DA, Rosenfeld MG, Gill GN: The role of tyrosine kinase activity in endocytosis, compartmentation, and down-regulation of the epidermal growth factor receptor. J Biol Chem 266:11083, 1991
37. Nosaka T, van Deursen JMA, Tripp RA, Thierfelder WE, Witthuhn BA, McMickle AP, Doherty PC, Grosveld GC, Ihle JN: Defective lymphoid development in mice lacking Jak3. Science 270:800, 1995
38. Peschon J, Morissey P, Grabstein K, Al E: Early lymphocyte expansion is severely impaired in interleukin-7 receptor-deficient mice. J Exp Med 180:1955, 1994
39. Freeden-Jeffry U, Vieira P, Lucian LA, McNeil T, Burdach SEG, Murray R: Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a non redundant cytokine. J Exp Med 181:1519, 1995
40. Disanto JP, Müller W, Guy-Grand D, Fischer A, Rajewsky K: Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor γ chain. Proc Natl Acad Sci USA 92:377, 1995
41. Moore TA, Zlotni Ak: T-cell lineage commitment and cytokine responses of thymic progenitors. Blood 86:1850, 1995
42. O'Reilly RJ, Keever CA, Small TN, Brochstein J: The use of HLA-non identical T cell-depleted marrow transplants for correction of SCID. Immunodef Rev 1:273, 1989
43. Fischer A, Landais P, Friedrich W, Morgan G, Gerritsen R, Fasth A, Porta V, Griscelli C, Goldmann SF, Levinsky R, Vossen J: The European experience of bone marrow transplantation for severe combined immunodeficiency. Lancet 336:850, 1990
44. lck: Identification of novel intermolecular association. Science 252:1523, 1991
45. lck. Proc Natl Acad Sci USA 88:1996, 1991
46. Torigoe T, Saragovi HU, Reed JC: Interleukin 2 regulates the activity of the lyn protein-tyrosine kinase in a B-cell line. Proc Natl Acad Sci USA 89:2674, 1992
47. lyn with the interleukin 2 receptor: Implications for redundancy and pleiotropism in cytokine signal transduction. Proc Natl Acad Sci USA 90:4201, 1993
48. Mills GB, May C, McGill M, Fung M, Baker M, Sutherland R, Greene WC: Interleukin 2-induced tyrosine phosphorylation: Interleukin 2 receptor β chain is tyrosine phosphorylated. J Biol Chem 265:3561, 1990
49. ras. Eur J Immunol 23:131, 1993
50. Satoh T, Minami Y, Kono T, Yamada K, Kawahara A, Taniguchi T, Kaziro Y: Interleukin 2-induced activation of ras requires two domains of interleukin 2 receptor β subunit, the essential region for growth stimulation and lck-binding domain. J Biol Chem 267:25423, 1992
51. Turner B, Rapp U, App H, Greene M, Dobashi K, Reed J: Interleukin 2 induces tyrosine phosphorylation and activation of p72-74 raf-1 kinase in a T-cell line. Proc Natl Acad Sci USA 88:1227, 1991
52. 1 and S in CD3-stimulated primary human T cells. Mol Cell Biol 11:2794, 1991
53. Augustine JA, Sutor SL, Abraham RT: Interleukin 2 and polyomavirus middle T antigen-induced modification of phosphatidylinositol 3-kinase activity in activated T lymphocytes. Mol Cell Biol 11:4431, 1991
54. Merida I, Williamson P, Kuziel WA, Greene WC, Gaulton GN: The serine-rich cytoplasmic domain of the interleukin 2 receptor β chain is essential for interleukin 2 dependent tyrosine protein kinase and phosphatidylinositol-3-kinase activation. J Biol Chem 268:6765, 1993
55. Remillard B, Petrillo R, Maslinski W, Tsudo M, Strom TB, Cantley L, Varticovski L: Interleukin-2 receptor regulates activation of phosphatidylinositol 3-kinase. J Biol Chem 266:14167, 1991
56. Ravichandran KS, Burakoff SJ: The adapter protein Shc interacts with the interkeukin-2 (IL-2) receptor upon IL-2 stimulation. J Biol Chem 269:1599, 1994
57. Dorsch M, Hock H, Diamantstein T: Gene transfer of the interleukin (IL)2 receptor β chain into an IL7 dependent pre-B cell line permits IL2 driven proliferation: Tyrosine phosphorylation of She is induced by IL2 but not IL7. Eur J Immunol 24:2049, 1994
58. Minami Y, Nakagawa Y, Kawahara A, Miyazaki T, Sada K, Yamamura H, Taniguchi T: Protein tyrosine kinase Syk is associated with and activated by the IL2 receptor: Possible link with the c-myc induction pathway. Cell 2:89, 1995
59. Pepper AE, Buckley RH, Small TN, Puck JM: Two mutational hotspots in the interleukin-2 receptor γ chain gene causing human X-linked severe combined immunodeficiency. Am J Hum Genet 57:564, 1995
60. Ishii N, Asao H, Kimura Y, Takeshita T, Nakamura M, Tsuchiya K, Konno T, Maeda M, Uchiyama T, Sugamura K: Impairment of ligand binding and growth signaling of mutant IL2 receptor γ chains in patients with X linked severe combined immunodeficiency. J Immunol 153:1310, 1994
61. de Saint Basile G, Le Deist F, Caniglia M, Lebranchu Y, Griscelli C, Fischer A: Genetic study of a new X-linked recessive immunodeficiency syndrome. J Clin Invest 89:861, 1992
62. Brooks EG, Schmalstieg FC, Wirt DP, Rosenblatt HM, Adkins LT, Lookingbill DP, Rudloff HE, Rakusan TA, Goldman AS: A novel X-linked combined immunodeficiency disease. J Clin Invest 86:1623, 1990
63. + peripheral blood T cells in a novel X-linked combined immunodeficiency disease. Eur J Immunol 22:1103, 1992
64. Ohta Y, Haire RN, Litman RT, Fu SM, Nelson RP, Kratz J, Kornfeld SJ, de la Morena M, Good RA, Litman GW: Genomic organization and structure of Bruton agammaglobulinemia tyrosine kinase: Localization of mutations associated with varied clinical presentations and course in X chromosome linked agammaglobulinemia. Proc Natl Acad Sci USA 91:9062, 1994
65. de Weers M, Mensink RGJ, Kraakman MEM, Schuurman RKB, Hendriks RW: Mutation analysis of the Bruton's tyrosine kinase gene in X-linked agammaglobulinemia: Identification of a mutation which affects the same codon as is altered in immunodeficient xid mice. Hum Mol Genet 3:161, 1994
66. Henthorn PS, Somberg RL, Fimiani VM, Puck JM, Patterson DF, Felsburg PJ: IL2Rγ gene microdeletion demonstrates that canine X-linked severe combined immunodeficiency is a homologue of the human disease. Genomics 23:69, 1994
67. Felsburg PJ, Somberg RL, Perryman LE: Domestic animal models of severe combined immunodeficiency: Canine X-linked severe combined immunodeficiency and severe combined immunodeficiency in horses. Immunodefic Rev 3:277, 1992
68. Ohbo K, Suda T, Hashiyama M, Mantani A, Ikebe M, Miyakawa K, Moriyama M, Nakamura M, Katsuki M, Takahashi K, Yamamura K, Sugamura K: Modulation of hematopoiesis in mice with a truncated mutant of the Interleukin-2 receptor γ chain. Blood 87:956, 1996